Company: LHI
Filing Date: 2025-01-27
Form Type: DRS/A
Source: 0001213900-25-006939
Chunk: 224

Company: Living Homeopathy International Ltd.
Filing Date: 2025-01-27
Form: DRS/A
Chunk 224
---
 more individuals, each of whom is an accredited investor; or (b) a trust (where the trustee is not an accredited
investor) whose sole purpose is to hold investments and each beneficiary of the trust is an individual who is an accredited investor; securities
(as defined in Section 239(1) of the SFA) of that corporation or the beneficiaries’ rights and interest in that trust
shall not be transferred within six months after that corporation or that trust has acquired the Class A Ordinary Shares under
Section 275 of the SFA, except: (1) to an institutional investor (for corporations under Section 274 of the SFA) or to
a relevant person defined in Section 275(2) of the SFA, or to any person pursuant to an offer that is made on terms that such
shares, debentures and units of shares and debentures of that corporation or such rights and interest in that trust are acquired at a
consideration of not less than S$200,000 (or its equivalent in a foreign currency) for each transaction, whether such amount is to be
paid for in cash or by exchange of securities or other assets, and further for corporations, in accordance with the conditions, specified
in Section 275 of the SFA; (2) where no consideration is or will be given for the transfer; or (3) where the transfer is
by operation of law.

Notice to Prospective Investors in Switzerland

The Class A Ordinary Shares will not be publicly
offered in Switzerland and will not be listed on the SIX Swiss Exchange, or SIX, or on any other stock exchange or regulated trading facility
in Switzerland. This prospectus has been prepared without regard to the disclosure standards for issuance prospectuses under art. 652a
or art. 1156 of the Swiss Code of Obligations or the disclosure standards for listing prospectuses under art. 27 ff. of the SIX Listing
Rules or the listing rules of any other stock exchange or regulated trading facility in Switzerland. Neither this prospectus nor any other
offering or marketing material relating to our company or the Class A Ordinary Shares have been or will be filed with or approved by any
Swiss regulatory authority. In particular, this prospectus will not be filed with, and the offer of the Class A Ordinary Shares will not
be supervised by, the Swiss Financial Market Supervisory Authority, and the offer of the ordinary shares has not been and will not be
authorized under the Swiss Federal Act